AbbVie remains king in doctors’ perception of immunology drugmakers, but J&J regains some ground

Just like last year, the Skyrizi and Rinvoq maker scored the highest by far in ZoomRx’s analysis of how healthcare providers view immunology drugmakers.

May 12, 2025 - 16:07
 0
AbbVie remains king in doctors’ perception of immunology drugmakers, but J&J regains some ground
Just like last year, the Skyrizi and Rinvoq maker scored the highest by far in ZoomRx’s analysis of how healthcare providers view immunology drugmakers.